Sofinnova Investments, Inc. Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$1.7T
Holdings
68
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (68 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera Inc | 3,102,960 | $289.8B | 16.93% | |
| 2 | KRTXKaruna Therapeutics, Inc. | 1,952,441 | $255.8B | 14.94% | |
| 3 | VERAVera Therapeutics, Inc. | 2,914,776 | $77.9B | 4.55% | |
| 4 | RHHBYRoche Holding AG | 1,369,011 | $70.8B | 4.13% | |
| 5 | ASNDAscendis Pharma A/S | 499,824 | $67.2B | 3.93% | |
| 6 | SPYSPDR S&P 500 ETF Trust | 100,000 | $47.5B | 2.77% | Put |
| 7 | AVTEAerovate Therapeutics, Inc. | 3,758,686 | $44.3B | 2.59% | |
| 8 | ABBVAbbvie Inc | 312,018 | $42.2B | 2.47% | |
| 9 | NDQInvesco QQQ Trust Series 1 | 100,000 | $39.8B | 2.32% | Put |
| 10 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $35.6B | 2.08% | |
| 11 | IWMiShares Russell 2000 ETF | 150,000 | $33.4B | 1.95% | Put |
| 12 | RGNXRegenxbio Inc | 1,008,081 | $33.0B | 1.93% | |
| 13 | TVTXTravere Therapeutics Inc | 1,040,858 | $32.3B | 1.89% | |
| 14 | UTHUnited Therapeutics Corp | 129,754 | $28.0B | 1.64% | |
| 15 | HRTXHeron Therapeutics Inc | 2,933,351 | $26.8B | 1.56% | |
| 16 | PTGXProtagonist Therapeutics Inc | 782,857 | $26.8B | 1.56% | Call |
| 17 | CCXIEURChemoCentryx Inc | 731,222 | $26.6B | 1.56% | |
| 18 | 2L9Blueprint Medicines Corp | 245,182 | $26.3B | 1.53% | |
| 19 | AFWAlign Technology Inc | 38,159 | $25.1B | 1.46% | |
| 20 | HZNPHorizon Therapeutics PLC | 221,792 | $23.9B | 1.40% | |
| 21 | GHGuardant Health Inc | 232,563 | $23.3B | 1.36% | |
| 22 | XNCRXencor Inc | 537,030 | $21.5B | 1.26% | |
| 23 | CYTKCytokinetics Inc | 464,366 | $21.2B | 1.24% | |
| 24 | BCRXBioCryst Pharmaceuticals Inc | 1,510,473 | $20.9B | 1.22% | |
| 25 | SNDXSyndax Pharmaceuticals Inc | 951,226 | $20.8B | 1.22% | |
| 26 | IRTCiRhythm Technologies Inc | 168,882 | $19.9B | 1.16% | |
| 27 | DC4Dexcom Inc | 32,404 | $17.4B | 1.02% | |
| 28 | INBXUSDInhibrx Inc | 368,679 | $16.1B | 0.94% | |
| 29 | NXTCNextcure, Inc | 2,671,856 | $16.0B | 0.94% | |
| 30 | GRTXGalera Therapeutics, Inc | 3,083,712 | $14.2B | 0.83% | |
| 31 | INZYInozyme Pharma, Inc. | 2,028,308 | $13.8B | 0.81% | |
| 32 | IMTXImmatics NV | 1,026,623 | $13.8B | 0.81% | |
| 33 | BOLT1EURBolt Biotherapeutics, Inc. | 2,754,437 | $13.5B | 0.79% | |
| 34 | OPHTEURIveric Bio Inc | 798,789 | $13.4B | 0.78% | |
| 35 | —Nucana Plc | 5,599,999 | $13.3B | 0.78% | |
| 36 | JNCEEURJounce Therapeutics Inc | 1,582,777 | $13.2B | 0.77% | |
| 37 | IMGNEURImmunoGen Inc | 1,749,882 | $13.0B | 0.76% | |
| 38 | —Akouos, Inc. | 1,515,074 | $12.9B | 0.75% | |
| 39 | IM8NInsmed Inc | 441,773 | $12.0B | 0.70% | |
| 40 | FULCFulcrum Therapeutics Inc | 617,670 | $10.9B | 0.64% | |
| 41 | SRPTSarepta Therapeutics Inc | 120,732 | $10.9B | 0.64% | |
| 42 | TCE2Celldex Therapeutics Inc | 271,533 | $10.5B | 0.61% | |
| 43 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $10.4B | 0.60% | |
| 44 | QUREUniqure NV | 495,025 | $10.3B | 0.60% | |
| 45 | —ObsEva SA | 4,749,623 | $9.5B | 0.55% | |
| 46 | VIRVir Biotechnology Inc | 200,000 | $8.4B | 0.49% | Put |
| 47 | BMRNBiomarin Pharmaceutical Inc | 87,322 | $7.7B | 0.45% | |
| 48 | KURAKura Oncology Inc | 544,173 | $7.6B | 0.44% | Call |
| 49 | —Zymeworks Inc | 392,712 | $6.4B | 0.38% | |
| 50 | AGENEURAgenus Inc | 1,961,032 | $6.3B | 0.37% | |
| 51 | —Nucana Plc | 2,400,000 | $5.7B | 0.33% | |
| 52 | IFRXInflarx NV | 1,161,736 | $5.5B | 0.32% | |
| 53 | TORCEURAdicet Bio Inc | 310,988 | $5.4B | 0.32% | |
| 54 | PTCTPTC Therapeutics Inc | 132,448 | $5.3B | 0.31% | |
| 55 | —Sierra Oncology Inc | 212,281 | $4.6B | 0.27% | |
| 56 | AXSMAxsome Therapeutics Inc | 100,000 | $3.8B | 0.22% | Put |
| 57 | NVCRNovocure Ltd | 50,000 | $3.8B | 0.22% | Call |
| 58 | ITCIEURIntra-Cellular Therapies Inc | 56,915 | $3.0B | 0.17% | |
| 59 | ICPTUSDIntercept Pharmaceuticals Inc | 150,400 | $2.5B | 0.14% | Call |
| 60 | CYTCyteir Therapeutics Inc | 179,450 | $2.0B | 0.12% | |
| 61 | MRNS*Marinus Pharmaceuticals Inc | 171,338 | $2.0B | 0.12% | |
| 62 | —Mink Therapeutics Inc | 345,499 | $1.5B | 0.09% | |
| 63 | ALGSAligos Therapeutics Inc | 127,791 | $1.5B | 0.09% | |
| 64 | —Synlogic Inc. | 574,972 | $1.4B | 0.08% | |
| 65 | PDSBPDS Biotechnology Corporation | 142,635 | $1.2B | 0.07% | |
| 66 | —Fusion Pharmaceuticals Inc | 78,066 | $326.0M | 0.02% | |
| 67 | PODDInsulet Corp | 1,066 | $284.0M | 0.02% | |
| 68 | EWEdwards Lifesciences Corp | 1,406 | $182.0M | 0.01% | |
| 69 | KRTXKaruna Therapeutics Inc | 636 | $83.0M | 0.00% |